Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD

Abstract Inhaled bronchodilators are central for the treatment of chronic obstructive pulmonary disease (COPD), as they can provide symptom relief and reduce the frequency and severity of exacerbations while improving health status and exercise tolerance. In 2017, glycopyrrolate (GLY) delivered via...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Donald P. Tashkin, Xiaoli Niu, Sanjay Sharma, Shahin Sanjar
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/34def7afb7e54f30b071260caa02f52c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!